Dare Bioscience (NASDAQ:DARE) reported its Q4 earnings results on Thursday, March 28, 2024 at 08:00 AM.
Here's what investors need to know about the announcement.
Earnings
Dare Bioscience beat estimated earnings by 40.0%, reporting an EPS of $-0.06 versus an estimate of $-0.1.
Revenue was up $1.81 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.01 which was followed by a 0.0% increase in the share price the next day.
To track all earnings releases for Dare Bioscience visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.